Navigation Links
Daiichi Sankyo's Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE and Prevention of its Recurrence
Date:8/31/2013

currence of venous thromboembolism (VTE) in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and for the prevention of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation, respectively.9

Edoxaban is currently approved only in Japan, since April 2011, for the prevention of VTE after major orthopedic surgery, and was launched in July 2011 under the brand name Lixiana®. Elsewhere, including Europe and the U.S., edoxaban is currently in phase 3 clinical development and has not been approved in any indication.10 Results from the ENGAGE AF-TIMI 48 study will be presented at the American Heart Association Scientific Sessions on November 19th, 2013.

About Daiichi Sankyo 

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit: www.daiichisankyo.com.

Contact
Michaela Paudler-Debus, PhD
Daiichi Sankyo Europe
michaela.paudler-debus@daiichi-sankyo.eu
+49 89 7808 685 (office)
+49 176 11780966 (mobile)

Forward-looking statements

This press release contains forward-looking statemen
'/>"/>

SOURCE Daiichi Sankyo Company, Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
2. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
3. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
4. Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Councils Chairman of the Board
5. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
6. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
7. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
8. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
9. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
10. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
11. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN DIEGO, July 31, 2014 Tandem Diabetes Care®, ... and manufacturer of the t:slim® Insulin Pump, today reported its ... In comparing the second quarter of 2014 to ... percent to $10.3 million from $5.5 million , t:slim ... pumps In comparing six months ended June 30, ...
(Date:7/31/2014)... , July 31, 2014  Alexza Pharmaceuticals, Inc. ... update on its pipeline and new product development ... to initiate a Phase 2a study of AZ-002 ... for the management of patients with acute repetitive ... Staccato -based product candidates for development - AZ-008 ...
(Date:7/31/2014)... July 31, 2014  Decision Resources Group is launching ... product Marketrack to now include ChinaTrack; the new capabilities ... in an interactive dashboard providing detailed brand-level share tracking ... a hospital level. Other key capabilities of ... feed: In addition to end-user surveys of healthcare facilities, ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
(Date:7/31/2014)... July 31, 2014 Bedford Commons ... firm Innerspire: Brand ReEnergizers to do what ... how we connect with the community all while still ... area practice, which caters to women’s health needs for ... and total women focused care ( Gynecology ), worked ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Dr. Andrew ... American Board of Dermatology, fellowship trained Mohs surgeon that ... Top Docs. , After extensive dermatology research training at ... Health, Dr. Li completed his internship in internal medicine ... University of Pennsylvania in Philadelphia. Dr. Li pursued further ...
(Date:7/31/2014)... has been rising steadily in the U.S in recent ... and Health, the number of individuals reporting past year ... (669,000). Emerging evidence suggests the increase may be linked ... and/or intranasal PO use to heroin use, with POs ... heroin injection. This drug-use trajectory appears to have ...
(Date:7/31/2014)... 2014 Model moms are believers. PBS has ... positions in the field have grown exponentially in the last ... thriving industry, there are associated myths that need to be ... Frontier Nursing University . Celebrating 75 years in 2014, ... in the nation. “Frontier is changing the face of ...
(Date:7/31/2014)... Infection prevention and control is the ... products in the pharma, medical device, and food industries. ... products and equipment types; the two procedures prevent the ... products. , The world market for infection prevention ... a CAGR of about 7.5% through to 2018. The ...
Breaking Medicine News(10 mins):Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4Health News:NJ Top Docs Proudly Presents Approved Provider, Dr. Andrew Li of Warren Skin Care Center 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 2Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 3
... from across Pennsylvania with substantial experience in ... Sept. 11 The Pennsylvania,Patient Safety Authority,s Board ... control experts to help implement Act 52 of ... Ed Rendell in July to help reduce and,eliminate ...
... Sally Watkins, PhD(c), MS, RN, has been named ... the Washington State Nurses,Association (WSNA), the State,s oldest ... are very fortunate to have in Sally Watkins ... and nurse advocate," said WSNA Executive,Director Judy Huntington, ...
... a mid-August edition of Circulation: Journal of the America Heart ... eating habits, it can strongly influence their heart disease risk ... Coronary Risk Factor Intervention Project have landmark implications on how ... a childs fat intake, primarily reduction in intake of saturated ...
... power industry is riding the green wave back into ... to our growing energy needs. But even as the ... play, it is bound by a global energy landscapefrom ... the marketplace. , Veteran New York Times energy ...
... shows no improvement with carvedilol , , TUESDAY, Sept. 11 (HealthDay News) ... that has been effective for adults with heart failure, did not ... rate of improvement -- and the lack of it -- was ... drug as it was for 54 youngsters who got a placebo. ...
... of prostate biopsies resulted in a cancer diagnosis among ... first biopsy did not find cancer often had multiple ... a cancer diagnosis. , While PSA (prostate-specific antigen) ... a biopsy is what actually determines the presence of ...
Cached Medicine News:Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 2Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 3Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 4Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 5Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 6Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 7Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 8Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 9Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Children who learn heart healthy eating habits lower heart disease risk 2Health News:Children who learn heart healthy eating habits lower heart disease risk 3Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Beta Blocker Doesn't Help Children With Heart Failure 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3
HbA1c / HbCalibrator...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
... Abnormal Control Plasmas for ... D-dimer and Free Protein ... For use with STA© ... D-DI (#0515) andSTA© LIATEST© ...
CRP Full Range (0.1-160mg/l)...
Medicine Products: